Japan approves Novo's new combination insulin Ryzodeg

COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk said on Tuesday Japan's health regulator had approved its new combination insulin, that it plans to market as Ryzodeg, for the treatment of diabetes. (Source: Reuters: Health)

Source: http://www.medworm.com/index.php?rid=6876998&cid=u_0_26_f&fid=23271&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Freuters%2FhealthNews%2F%7E3%2Fv8DjA_NIt6E%2Fus-novonordisk-idUSBRE8BO02F20121225

phlebotomy certification in florida phlebotomy certification florida phlebotomy classes in ri